HighTower Advisors, LLC - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 55 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$3,000
-25.0%
10,2000.0%0.00%
Q4 2019$4,000
+33.3%
10,2000.0%0.00%
Q3 2019$3,0000.0%10,200
-6.4%
0.00%
Q2 2019$3,000
-75.0%
10,900
-15.5%
0.00%
Q1 2019$12,000
-36.8%
12,900
+18.3%
0.00%
Q4 2018$19,000
-69.8%
10,9000.0%0.00%
Q3 2018$63,00010,9000.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Kalos Management, Inc. 47,500$12,0000.01%
Virtu Financial LLC 94,842$25,0000.00%
ACADIAN ASSET MANAGEMENT LLC 467,425$121,0000.00%
REILLY FINANCIAL ADVISORS, LLC 22,011$6,0000.00%
A.R.T. Advisors, LLC 60,430$16,0000.00%
GOLDMAN SACHS GROUP INC 25,350$7,0000.00%
MORGAN STANLEY 1,019$00.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 24,900$6,0000.00%
WOLVERINE TRADING, LLC 30,900$8,0000.00%
WOLVERINE TRADING, LLC 26,779$7,0000.00%
View complete list of CONATUS PHARMACEUTICALS INC shareholders